~~<i id='587ACA244F'><strike id='587ACA244F'><tt id='587ACA244F'><pre id='587ACA244F'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

leisure time

author：Wikipedia 2025-10-01 02:14:46 - browse：554

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Choosing scientific sides in the fight against Alzheimer's

Wikipedia

focus

knowledge

explore

entertainment

hotspot

JasonFarley,directoroftheCenterforInfectiousDiseaseandNursingInnovationatJohnsHopkinsUniversity,atth

WSS

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

A letter from the executive editor: STAT UnitedHealth investigation

CVS, Rite Aid closures threaten to worsen pharmacy deserts

Mega Millions jackpot estimated at record $1.58 billion for Tuesday's drawing

CVS, Rite Aid closures threaten to worsen pharmacy deserts

'Of course' Trump lost the 2020 election, DeSantis says after years of hedging

hotspot

leisure time

Wikipedia

Medical records are filled with copy

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Today's health inequities arise from racist U.S. history, say experts

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

The high cost of giving birth even with insurance

Travel bans should be based on evidence, not politics or fear

Apple is now the first public company to be valued at $3 trillion

NIH chief: government has fallen behind pharma on clinical trials

focus

Boston man files lawsuit seeking to bankrupt white supremacist group he says assaulted him

Wegovy cuts risk of cardiovascular events by 20%, study finds

Ventyx halts psoriasis drug development after lackluster trial results

Can Threads overtake X, formerly known as Twitter? Experts weigh in.

FTX founder Sam Bankman

Ventyx halts psoriasis drug development after lackluster trial results

knowledge

explore

entertainment

hotspot